Frank M. Fischer

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Tenon Medical Inc., 3 years.

3 years ยท Since 2023
Neuropace Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 19, 2026 Neuropace Inc. Grant or award +1,467 $15.63 $22,929
Jun 5, 2026 Neuropace Inc. Grant or award +2,890 โ€” โ€”
Mar 20, 2026 Neuropace Inc. Grant or award +1,826 $13.00 $23,738
Dec 19, 2025 Neuropace Inc. Grant or award +1,431 $16.59 $23,740
Sep 19, 2025 Neuropace Inc. Grant or award +2,389 $9.94 $23,747
Jun 21, 2025 Neuropace Inc. Grant or award +2,281 $10.41 $23,745
Mar 21, 2025 Neuropace Inc. Grant or award +1,975 $12.02 $23,740
Dec 21, 2024 Neuropace Inc. Grant or award +2,059 $11.53 $23,740
Sep 30, 2024 Neuropace Inc. Grant or award +3,407 $6.97 $23,747
Jun 28, 2024 Neuropace Inc. Grant or award +3,141 $7.56 $23,746
Mar 29, 2024 Neuropace Inc. Grant or award +1,799 $13.20 $23,747
Dec 29, 2023 Neuropace Inc. Grant or award +2,303 $10.31 $23,744
Sep 29, 2023 Neuropace Inc. Grant or award +2,440 $9.73 $23,741
Jun 30, 2023 Neuropace Inc. Grant or award +4,469 $4.49 $20,066
May 22, 2023 Tenon Medical Inc. Option exercise +6,207 $1.62 $10,055

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.